Skip to main content
رجوع
TNDM logo

Tandem Diabetes Care, Inc.

جودة البيانات: 100%
TNDM
NASDAQ Healthcare Medical - Devices
KWD 25.09
▲ KWD 0.27 (1.09%)
القيمة السوقية: 1.71B
نطاق اليوم
KWD 24.96 KWD 26.38
نطاق 52 أسبوعًا
KWD 9.98 KWD 29.65
حجم التداول
2,089,481
متوسط 50 يوم / 200 يوم
KWD 21.55 / KWD 17.77
الإغلاق السابق
KWD 24.82

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -8.4 0.4
P/B 11.1 2.9
ROE % -97.9 3.8
Net Margin % -20.2 3.9
Rev Growth 5Y % 9.6 10.0
D/E 2.9 0.2

السعر المستهدف للمحللين

Hold
KWD 30.500 +21.6%
Low: KWD 21.000 High: KWD 56.000
ربحية السهم المستقبلية
-KWD 0.757
الإيرادات المقدّرة
1.1 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.760
KWD 1.704 – KWD 1.836
1.6 B 3
FY2029 KWD 1.295
KWD 1.253 – KWD 1.350
1.5 B 3
FY2028 KWD 0.633
KWD 0.385 – KWD 1.274
1.4 B 9

النقاط الرئيسية

Revenue grew 9.62% annually over 5 years — modest growth
Debt/Equity of 2.86 — high leverage
Negative free cash flow of -29.67M
Capital efficient — spends only 1.97% of revenue on capex

النمو

Revenue Growth (5Y)
9.62%
Revenue (1Y)7.93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-97.88%
ROIC-9.77%
Net Margin-20.17%
Op. Margin-7.70%

الأمان

Debt / Equity
2.86
Current Ratio2.55
Interest Coverage-9.88

التقييم

P/E Ratio
-8.37
P/B Ratio11.05
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.93% Revenue Growth (3Y) 16.50%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9.62% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.01B Net Income (TTM) -204.71M
ROE -97.88% ROA -23.23%
Gross Margin 52.31% Operating Margin -7.70%
Net Margin -20.17% Free Cash Flow (TTM) -29.67M
ROIC -9.77% FCF Growth (3Y) N/A
Safety
Debt / Equity 2.86 Current Ratio 2.55
Interest Coverage -9.88 Dividend Yield 0.00%
Valuation
P/E Ratio -8.37 P/B Ratio 11.05
P/S Ratio 1.69 PEG Ratio -0.07
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.71B Enterprise Value 2.07B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.01B 940.20M 747.72M 801.22M 702.80M
Net Income -204.71M -96.03M -222.61M -94.59M 15.57M
EPS (Diluted) -3.04 -1.47 -3.43 -1.47 0.24
Gross Profit 530.85M 489.57M 367.69M 412.99M 376.22M
Operating Income -78.12M -99.13M -233.23M -92.85M 22.65M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 881.11M 967.66M 952.66M 1.05B 905.14M
Total Liabilities 725.94M 704.56M 639.03M 612.84M 472.03M
Shareholders' Equity 155.17M 263.10M 313.63M 439.95M 433.11M
Total Debt 444.48M 473.57M 415.67M 419.88M 314.67M
Cash & Equivalents 90.63M 69.23M 58.87M 172.52M 71.18M
Current Assets 618.14M 724.49M 747.99M 849.98M 811.52M
Current Liabilities 242.72M 247.05M 195.26M 165.29M 131.86M